For investors looking for a dependable source of passive income, a methodical screening process is needed to distinguish truly lasting dividend payers from those with risky, high yields. A typical method involves selecting for companies that not only rate well on dividend-focused measures but also show good core business condition and earnings. This method seeks to find firms with the monetary resources to keep and possibly raise their payments over time, rather than those whose high yields might signal a falling stock price or unsound basics. One stock that appears from this type of filter is healthcare leader Abbott Laboratories (NYSE:ABT).
Examining the Dividend Details
Abbott Laboratories makes a strong argument for dividend-oriented investors, mainly seen in its solid ChartMill Dividend Rating of 7 out of 10. This rating combines a number of important elements that dividend investors value.
- Yield and Growth: Abbott provides a fair dividend yield of 2.17%, which is sensible next to the S&P 500 average and clearly superior to most of its competitors in the Health Care Equipment & Supplies industry. More notable is its record of steady growth; the company has raised its dividend for at least 10 straight years, with an average yearly growth rate near 11.4% over the last five years. This history of dependable yearly increases is a sign of a company that respects shareholders and manages money carefully.
- Dividend Security: The security of a dividend is possibly more critical than its present amount. Here, Abbott stands out with a very low payout ratio. The company uses only about 28.93% of its earnings for dividend payments, leaving a large buffer to fund business operations, handle economic slowdowns, or keep increasing the dividend. This small ratio shows the current dividend is very secure and not endangered by small changes in earnings.
Backing Basics: Earnings and Condition
A good dividend rests on a base of an earning and monetarily stable business. Abbott’s screening outcomes point out "acceptable earnings and condition," which are vital for the lasting endurance of its shareholder payments. The complete fundamental analysis report supplies the proof.
- Earnings Quality: Abbott receives a high ChartMill Profitability Rating of 7. The company earns strong profits, with margins that rank with the top in its field. Its Return on Equity (ROE) of 27.43% and Return on Assets (ROA) of 16.60% are much better than most rivals. Good and improving profit margins create the cash needed to pay for the dividend without stressing the company's accounts.
- Monetary Condition Review: The company has a ChartMill Health Rating of 5, showing an adequate monetary state with certain points to watch. On the good side, Abbott carries a very workable amount of debt, with a small Debt-to-Equity ratio of 0.23 and a good Debt-to-Free-Cash-Flow ratio, meaning it can settle its debts fast. Still, the report mentions that its current and quick liquidity ratios are under the industry average, which is an item for investors to note, although not a direct concern considering the company's overall ability to generate cash.
Price and Expansion Background
While the main aim is on income, total return factors are important. Abbott's price looks fair inside its industry. Its Price-to-Earnings (P/E) ratio is smaller than many industry peers, and its Price-to-Free-Cash-Flow ratio points to a relatively low price compared to the sector. This implies the stock is not extremely costly, which can be a danger for dividend investors if a high price leads to a drop that cancels out yield.
Expansion outlooks are consistent, with analysts predicting both earnings and sales to improve somewhat in the next few years. This expected growth backs the chance for ongoing dividend raises, matching the company's notable past record.
Final Thoughts and More Study
Abbott Laboratories shows the kind of company a "Best Dividend" screen is meant to find: one with an appealing, well-backed, and increasing dividend supported by an earning and basically sound business. Its established brand collection in steady healthcare areas, reliable performance, and shareholder-minded capital distribution policy make it a common holding in many dividend portfolios.
For investors wanting to review other companies that fit similar standards of high dividend quality, good earnings, and stable monetary condition, the fully set Best Dividend Stocks screen is a good beginning for more study.
Disclaimer: This article is for information only and does not form financial guidance, an endorsement, or a bid to buy or sell any securities. The information shown is from supplied data and should not be the only ground for any investment choice. Investors must perform their own review and talk with a certified financial consultant before making any investment decisions. Past results do not guarantee future outcomes.